| 公開(kāi)(公告)號(hào) | CN1934250A |
| 公開(kāi)(公告)日 | 2007.03.21 |
| 申請(qǐng)(專(zhuān)利)號(hào) | CN200580009090.X |
| 申請(qǐng)日期 | 2005.03.10 |
| 專(zhuān)利名稱(chēng) | 新的醇脫氫酶 |
| 主分類(lèi)號(hào) | C12N9/04(2006.01)I |
| 分類(lèi)號(hào) | C12N9/04(2006.01)I;C12N15/31(2006.01)I |
| 分案原申請(qǐng)?zhí)? | |
| 優(yōu)先權(quán) | 2004.3.22 DE 102004014274.2 |
| 申請(qǐng)(專(zhuān)利權(quán))人 | 德古薩股份公司 |
| 發(fā)明(設(shè)計(jì))人 | 雷娜特·舒爾策;帕特里克·洛倫茨;于爾根·�？�;奧利弗·邁;哈拉爾德·格勒格爾;哈拉爾德·特勞特韋因 |
| 地址 | 德國(guó)杜塞爾多夫市 |
| 頒證日 | |
| 國(guó)際申請(qǐng) | 2005-03-10 PCT/EP2005/002557 |
| 進(jìn)入國(guó)家日期 | 2006.09.21 |
| 專(zhuān)利代理機(jī)構(gòu) | 永新專(zhuān)利商標(biāo)代理有限公司 |
| 代理人 | 林曉紅 |
| 國(guó)省代碼 | 德國(guó);DE |
| 主權(quán)項(xiàng) | A pe which has the biologicalactivity of an dependentac and which comprises or has one of the followingaacid csthe sce ofthesce ofthe sce ofr a sce which isat leastcal to the sce of，the sce ofthe sce of r asce which is at leastcal to the sce of，the sce ofasce which is at leastidentical to the sce of，the sceof a sequence which is at least cal to the sce of，thesce ofa sce which is at least cal to the sce of，thesce ofa sce which is at least cal to the sce of，thesce of a sce which is at leastcal to the sce of S，thesce ofr a sce which is at leastcal to the sce of，the sce of a sce which is at leastcal to the sce ofS，the sce ofa sce which is at least cal to the sce of，the sce ofa sce which is at leastcal to the sce of，the sce ofa sce which is at leastcal to the sce of，the sce ofa sce which is atleast cal to the sce of，the sce of a sce which is atleastcal to the sce of，the sce ofa sce which is at leastcal to the sce of，the sce ofa sce which is at leastcal to the sce of，the sce of a sequence which is at least cal to the sceof，the sce ofa sce which is at least cal to the sceof，the sce ofa sce which is at least cal to the sceofthe sce of a sce which is at leastcal to the sceofthe sce ofa sce which is at leastcal to the sce of，the sce ofa sce which is atleast cal to the sequenceof the sce ofa sce which is at least cal to the sceofthe sce ofa sce which is atleastcal to the sce of，the sce ofa sce which is at least cal to the sce ofthe sce of a sce which is at least 70cal tothe sceofthe sce ofr a sce which is at leastcal to the sceof，the sce of a sce which is at least cal to the sceofthe sce of r a sce which is at lesst cal to the sceofthe sce ofthe sce of |
| 摘要 | 本發(fā)明涉及具有NAD-或者NADP-依賴(lài)性醇脫氫酶生物活性的新多肽。本發(fā)明還涉及編碼所述多肽的核酸、非人宿主或者宿主細(xì)胞及可用于制備所需產(chǎn)物的反應(yīng)系統(tǒng)。本發(fā)明的多肽優(yōu)選用于從醛或者酮開(kāi)始制備伯醇和對(duì)映異構(gòu)體純的仲醇，所述醇可作為藥物的中間體�；蛘撸景l(fā)明的多肽也可用于逆反應(yīng)中，即用于醇的氧化反應(yīng)形成醛或者酮。 |
| 國(guó)際公布 | 2005-11-03 WO2005/103239 英 |
